Literature DB >> 22790176

A controlled study of agoraphobia and the independent effect of virtual reality exposure therapy.

Eric Malbos1, Ronald M Rapee, Manolya Kavakli.   

Abstract

OBJECTIVES: Past controlled clinical trials centred on virtual reality exposure therapy (VRET) for agoraphobia mostly used multicomponent therapy with success. However, the present paper aimed to evaluate the independent effect of VRET for agoraphobia.
METHODS: A controlled study involving 18 agoraphobic participants assigned to two groups: VRET only and VRET with cognitive therapy. Nine specific virtual environments were developed using an affordable game level editor.
RESULTS: Questionnaires, behavioural tests and physiological measures indicated a positive effect of VRET. Correlations supported the predictive value of presence towards treatment outcome. The addition of cognitive therapy did not provide significant additional benefit.
CONCLUSIONS: Overall, the isolated effects of VRET did not seem to be significantly less than the effects of VRET combined with cognitive therapy. Future research should explore the use of other components in addition to cognitive therapy and VRET for agoraphobia as well as its possible use in patients' homes.

Entities:  

Mesh:

Year:  2012        PMID: 22790176     DOI: 10.1177/0004867412453626

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  13 in total

1.  Telemental health: A status update.

Authors:  Elias Aboujaoude; Wael Salame; Lama Naim
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 2.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

Review 3.  Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review.

Authors:  Cristina Botella; Javier Fernández-Álvarez; Verónica Guillén; Azucena García-Palacios; Rosa Baños
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

4.  Virtual reality cue exposure for the relapse prevention of tobacco consumption: a study protocol for a randomized controlled trial.

Authors:  Camille Giovancarli; Eric Malbos; Karine Baumstarck; Nathalie Parola; Marie-Florence Pélissier; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Trials       Date:  2016-02-19       Impact factor: 2.279

5.  Virtual Reality Exposure Therapy for Anxiety Disorders: Small Samples and No Controls?

Authors:  Sarah Page; Matthew Coxon
Journal:  Front Psychol       Date:  2016-03-11

Review 6.  A prescription for "nature" - the potential of using virtual nature in therapeutics.

Authors:  Matthew P White; Nicola L Yeo; Peeter Vassiljev; Rikard Lundstedt; Mattias Wallergård; Maria Albin; Mare Lõhmus
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-08       Impact factor: 2.570

Review 7.  Head-Mounted Virtual Reality and Mental Health: Critical Review of Current Research.

Authors:  Shaun W Jerdan; Mark Grindle; Hugo C van Woerden; Maged N Kamel Boulos
Journal:  JMIR Serious Games       Date:  2018-07-06       Impact factor: 4.143

8.  Virtual Reality Smartphone-Based Intervention for Smoking Cessation: Pilot Randomized Controlled Trial on Initial Clinical Efficacy and Adherence.

Authors:  Emilio Goldenhersch; Johannes Thrul; Joaquín Ungaretti; Nicolas Rosencovich; Cristian Waitman; Marcelo Rodriguez Ceberio
Journal:  J Med Internet Res       Date:  2020-07-29       Impact factor: 5.428

Review 9.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13

10.  A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders.

Authors:  Yun Ling; Harold T Nefs; Nexhmedin Morina; Ingrid Heynderickx; Willem-Paul Brinkman
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.